BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stone D, Niyonzima N, Jerome KR. Genome editing and the next generation of antiviral therapy. Hum Genet 2016;135:1071-82. [PMID: 27272125 DOI: 10.1007/s00439-016-1686-2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Kwarteng A, Ahuno ST, Kwakye-Nuako G. The therapeutic landscape of HIV-1 via genome editing. AIDS Res Ther 2017;14:32. [PMID: 28705213 DOI: 10.1186/s12981-017-0157-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
2 Aubert M, Strongin DE, Roychoudhury P, Loprieno MA, Haick AK, Klouser LM, Stensland L, Huang ML, Makhsous N, Tait A, De Silva Feelixge HS, Galetto R, Duchateau P, Greninger AL, Stone D, Jerome KR. Gene editing and elimination of latent herpes simplex virus in vivo. Nat Commun 2020;11:4148. [PMID: 32811834 DOI: 10.1038/s41467-020-17936-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
3 Kato Y, Tabata H, Sato K, Nakamura M, Saito I, Nakanishi T. Adenovirus Vectors Expressing Eight Multiplex Guide RNAs of CRISPR/Cas9 Efficiently Disrupted Diverse Hepatitis B Virus Gene Derived from Heterogeneous Patient. Int J Mol Sci 2021;22:10570. [PMID: 34638909 DOI: 10.3390/ijms221910570] [Reference Citation Analysis]
4 Darcis G, Binda CS, Klaver B, Herrera-Carrillo E, Berkhout B, Das AT. The Impact of HIV-1 Genetic Diversity on CRISPR-Cas9 Antiviral Activity and Viral Escape. Viruses 2019;11:E255. [PMID: 30871200 DOI: 10.3390/v11030255] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
5 Colón-Thillet R, Jerome KR, Stone D. Optimization of AAV vectors to target persistent viral reservoirs. Virol J 2021;18:85. [PMID: 33892762 DOI: 10.1186/s12985-021-01555-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Chen SH, Hsieh YY, Tzeng HE, Lin CY, Hsu KW, Chiang YS, Lin SM, Su MJ, Hsieh WS, Lee CH. ABL Genomic Editing Sufficiently Abolishes Oncogenesis of Human Chronic Myeloid Leukemia Cells In Vitro and In Vivo. Cancers (Basel) 2020;12:E1399. [PMID: 32485885 DOI: 10.3390/cancers12061399] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Nagamoto S, Agawa M, Tsuchitani E, Akimoto K, Matsushima SK, Kanegae Y. Short term but highly efficient Cas9 expression mediated by excisional system using adenovirus vector and Cre. Sci Rep 2021;11:24369. [PMID: 34934130 DOI: 10.1038/s41598-021-03803-w] [Reference Citation Analysis]
8 Moschos SA, Usher L, Lindsay MA. Clinical potential of oligonucleotide-based therapeutics in the respiratory system. Pharmacol Ther 2017;169:83-103. [PMID: 27771436 DOI: 10.1016/j.pharmthera.2016.10.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
9 Wang G, Zhao N, Berkhout B, Das AT. CRISPR-Cas based antiviral strategies against HIV-1. Virus Research 2018;244:321-32. [DOI: 10.1016/j.virusres.2017.07.020] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 12.3] [Reference Citation Analysis]
10 Moos WH, Pinkert CA, Irwin MH, Faller DV, Kodukula K, Glavas IP, Steliou K. Epigenetic Treatment of Persistent Viral Infections. Drug Dev Res 2017;78:24-36. [PMID: 27761936 DOI: 10.1002/ddr.21366] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
11 Khodavirdipour A, Zarean R, Safaralizadeh R. Evaluation of the Anti-cancer Effect of Syzygium cumini Ethanolic Extract on HT-29 Colorectal Cell Line. J Gastrointest Cancer 2021;52:575-81. [PMID: 32506290 DOI: 10.1007/s12029-020-00439-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
12 Li W, Liu Y, Wang Y, Li R, Trang P, Tang W, Yang Z, Wang Y, Sun X, Xing X, Lu S, Liu F. Engineered RNase P Ribozymes Effectively Inhibit the Infection of Murine Cytomegalovirus in Animals. Theranostics 2018;8:5634-44. [PMID: 30555569 DOI: 10.7150/thno.27776] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Ho BX, Loh SJH, Chan WK, Soh BS. In Vivo Genome Editing as a Therapeutic Approach. Int J Mol Sci 2018;19:E2721. [PMID: 30213032 DOI: 10.3390/ijms19092721] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 8.3] [Reference Citation Analysis]
14 Gergen J, Coulon F, Creneguy A, Elain-Duret N, Gutierrez A, Pinkenburg O, Verhoeyen E, Anegon I, Nguyen TH, Halary FA, Haspot F. Multiplex CRISPR/Cas9 system impairs HCMV replication by excising an essential viral gene. PLoS One 2018;13:e0192602. [PMID: 29447206 DOI: 10.1371/journal.pone.0192602] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
15 Rogers GL, Cannon PM. Gene Therapy Approaches to Human Immunodeficiency Virus and Other Infectious Diseases. Hematol Oncol Clin North Am 2017;31:883-95. [PMID: 28895854 DOI: 10.1016/j.hoc.2017.06.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
16 Das AT, Binda CS, Berkhout B. Elimination of infectious HIV DNA by CRISPR-Cas9. Curr Opin Virol 2019;38:81-8. [PMID: 31450074 DOI: 10.1016/j.coviro.2019.07.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
17 Stone D, Long KR, Loprieno MA, De Silva Feelixge HS, Kenkel EJ, Liley RM, Rapp S, Roychoudhury P, Nguyen T, Stensland L, Colón-Thillet R, Klouser LM, Weber ND, Le C, Wagoner J, Goecker EA, Li AZ, Eichholz K, Corey L, Tyrrell DL, Greninger AL, Huang ML, Polyak SJ, Aubert M, Sagartz JE, Jerome KR. CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized mice. Mol Ther Methods Clin Dev 2021;20:258-75. [PMID: 33473359 DOI: 10.1016/j.omtm.2020.11.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
18 Perez-Pinera P, Chen ZY. Biomedical applications of gene editing. Hum Genet 2016;135:967-9. [PMID: 27535845 DOI: 10.1007/s00439-016-1723-1] [Reference Citation Analysis]
19 Cao JY, Lin Y, Han YF, Ding SH, Fan YL, Pan YH, Zhao B, Guo QH, Sun WH, Wan JQ, Tong XP. Expression of nerve growth factor carried by pseudotyped lentivirus improves neuron survival and cognitive functional recovery of post-ischemia in rats. CNS Neurosci Ther 2018;24:508-18. [PMID: 29409115 DOI: 10.1111/cns.12818] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
20 Pieknik JR, Bertke AS, Krause PR. Herpes Simplex Virus 2 in Autonomic Ganglia: Evidence for Spontaneous Reactivation. J Virol 2019;93:e00227-19. [PMID: 30894469 DOI: 10.1128/JVI.00227-19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
21 Chen SH, Hsieh YY, Tzeng HE, Lin CY, Hsu KW, Chiang YS, Lin SM, Su MJ, Hsieh WS, Lee CH. ABL Genomic Editing Sufficiently Abolishes Oncogenesis of Human Chronic Myeloid Leukemia Cells In Vitro and In Vivo. Cancers (Basel) 2020;12:E1399. [PMID: 32485885 DOI: 10.3390/cancers12061399] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
22 Bardakjian T, Gonzalez-alegre P. Towards precision medicine. Neurogenetics, Part I. Elsevier; 2018. pp. 93-102. [DOI: 10.1016/b978-0-444-63233-3.00008-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
23 Jerome KR. Disruption or Excision of Provirus as an Approach to HIV Cure. AIDS Patient Care STDS 2016;30:551-5. [PMID: 27855263 DOI: 10.1089/apc.2016.0232] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
24 Li W, Sheng J, Xu M, Vu GP, Yang Z, Liu Y, Sun X, Trang P, Lu S, Liu F. Inhibition of Murine Cytomegalovirus Infection in Animals by RNase P-Associated External Guide Sequences. Mol Ther Nucleic Acids 2017;9:322-32. [PMID: 29246310 DOI: 10.1016/j.omtn.2017.10.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
25 Li X, Ma C, Luo H, Zhang J, Wang J, Guo H. Identification of the differential expression of genes and upstream microRNAs in small cell lung cancer compared with normal lung based on bioinformatics analysis. Medicine (Baltimore) 2020;99:e19086. [PMID: 32176034 DOI: 10.1097/MD.0000000000019086] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
26 Togtema M, Hussack G, Dayer G, Teghtmeyer MR, Raphael S, Tanha J, Zehbe I. Single-Domain Antibodies Represent Novel Alternatives to Monoclonal Antibodies as Targeting Agents against the Human Papillomavirus 16 E6 Protein. Int J Mol Sci 2019;20:E2088. [PMID: 31035322 DOI: 10.3390/ijms20092088] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
27 Yu L, Tian X, Gao C, Wu P, Wang L, Feng B, Li X, Wang H, Ma D, Hu Z. Genome editing for the treatment of tumorigenic viral infections and virus-related carcinomas. Front Med 2018;12:497-508. [PMID: 29651774 DOI: 10.1007/s11684-017-0572-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Füchtbauer AF, Preus S, Börjesson K, McPhee SA, Lilley DMJ, Wilhelmsson LM. Fluorescent RNA cytosine analogue - an internal probe for detailed structure and dynamics investigations. Sci Rep 2017;7:2393. [PMID: 28539582 DOI: 10.1038/s41598-017-02453-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
29 Togtema M, Jackson R, Grochowski J, Villa PL, Mellerup M, Chattopadhyaya J, Zehbe I. Synthetic siRNA targeting human papillomavirus 16 E6: a perspective on in vitro nanotherapeutic approaches. Nanomedicine (Lond) 2018;13:455-74. [PMID: 29382252 DOI: 10.2217/nnm-2017-0242] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
30 Yang YC, Chen YH, Kao JH, Ching C, Liu IJ, Wang CC, Tsai CH, Wu FY, Liu CJ, Chen PJ, Chen DS, Yang HC. Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing. Mol Ther Nucleic Acids. 2020;20:480-490. [PMID: 32278307 DOI: 10.1016/j.omtn.2020.03.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
31 De Silva Feelixge HS, Stone D, Roychoudhury P, Aubert M, Jerome KR. CRISPR/Cas9 and Genome Editing for Viral Disease-Is Resistance Futile? ACS Infect Dis 2018;4:871-80. [PMID: 29522311 DOI: 10.1021/acsinfecdis.7b00273] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
32 De Silva Feelixge HS, Jerome KR. Excision of Latent HIV-1 from Infected Cells In Vivo: An Important Step Forward. Mol Ther 2017;25:1062-4. [PMID: 28462817 DOI: 10.1016/j.ymthe.2017.04.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]